Where it started
Originally developing tests for Water Quality, Food Safety, and Pharma Quality Control, BioGX has since created one of the largest portfolios of lyophilized syndromic multiplexes for infectious diseases.
A global molecular diagnostics solution provider for better health and safety of communities worldwide, leading the way for simple yet superior molecular diagnostics.
BioGX is a global molecular diagnostics solution provider for better health and safety of communities worldwide. Originally developing tests for Water Quality, Food Safety, and Pharma Quality Control, the company has since created one of the largest portfolios of lyophilized syndromic multiplexes for infectious diseases, leading the way for simple yet superior molecular diagnostics.

How a company that began with water, food and pharma testing became a global provider of lyophilized, Sample-Ready™ molecular diagnostics.
Originally developing tests for Water Quality, Food Safety, and Pharma Quality Control, BioGX has since created one of the largest portfolios of lyophilized syndromic multiplexes for infectious diseases.

Headquartered in Alabama, USA, BioGX’s American footprint allows for the manufacture of custom-designed, platform agnostic Sample-Ready™ reagents for Laboratory Developed Tests (USA only).

Using real-time PCR, BioGX makes molecular testing easy for labs with its novel Sample-Ready™ approach to LDTs, which enable a lab to specify its choice of test and receive a high-performance mix of all the necessary reagents, primers and probes, lyophilized and in one tube without the need for refrigeration. The proprietary Sample-Ready™ technology is at the core of the company’s worldwide offerings across clinical, food safety, pharma and water quality testing.

Wholly owned subsidiary, BioGX BV, is located in Amsterdam, The Netherlands and boasts a large portfolio of CE-IVD marked tests, spread across a wide variety of infectious diseases ranging from COVID-19, respiratory to sexual health, enteric pathogens, drug resistance, meningitis, transplant and tropical disease. With our Global Partnership Initiative, we can supply the rest of the world with our products, fast and effectively.
All BioGX reagents are fine-tuned to ensure the highest performance in any lab setting, even outer space, where our products are currently used in the International Space Station.
Through continuous innovation our team of scientists aim to make real-time PCR as simple, robust and efficient for laboratories all over the world.
BioGX is headquartered in Birmingham, Alabama. This location hosts the company’s research and development laboratories and a fully scaled production and manufacturing facility. The company also holds a subsidiary in Amsterdam, The Netherlands, BioGX BV. Acting as the BioGX source for global distribution to over 100 countries worldwide.
We have assembled a highly talented management team with decades of individual experience successfully developing and commercializing innovative clinical and molecular diagnostic products.
BioGX is a growing company. We are always on the lookout for talented scientists and technicians with an entrepreneurial spirit, a dedication to excellence, and experience with molecular biology. We offer a competitive salary and benefits package.